7.13
price up icon6.10%   0.41
 
loading
Precedente Chiudi:
$6.72
Aprire:
$6.76
Volume 24 ore:
3.88M
Relative Volume:
0.98
Capitalizzazione di mercato:
$1.16B
Reddito:
$1.08B
Utile/perdita netta:
$422.82M
Rapporto P/E:
3.1272
EPS:
2.28
Flusso di cassa netto:
$-637.33M
1 W Prestazione:
+4.39%
1M Prestazione:
+8.03%
6M Prestazione:
+5.47%
1 anno Prestazione:
-16.80%
Intervallo 1D:
Value
$6.76
$7.195
Intervallo di 1 settimana:
Value
$6.595
$7.195
Portata 52W:
Value
$5.01
$11.55

Novavax Inc Stock (NVAX) Company Profile

Name
Nome
Novavax Inc
Name
Telefono
240-268-2000
Name
Indirizzo
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
Dipendente
1,992
Name
Cinguettio
@novavax
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
NVAX's Discussions on Twitter

Confronta NVAX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NVAX
Novavax Inc
7.13 1.09B 1.08B 422.82M -637.33M 2.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.13 115.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
776.31 81.12B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
400.17 52.54B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
839.99 51.78B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
177.12 37.12B 447.02M -1.18B -906.14M -6.1812

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-24 Ripresa Cantor Fitzgerald Overweight
2025-08-28 Ripresa H.C. Wainwright Buy
2025-08-20 Downgrade BofA Securities Neutral → Underperform
2025-06-17 Iniziato Citigroup Sell
2025-02-28 Iniziato BTIG Research Buy
2024-07-30 Downgrade JP Morgan Neutral → Underweight
2024-05-10 Aggiornamento BofA Securities Underperform → Neutral
2024-05-10 Aggiornamento JP Morgan Underweight → Neutral
2023-08-09 Aggiornamento B. Riley Securities Neutral → Buy
2023-04-20 Downgrade TD Cowen Outperform → Market Perform
2023-03-01 Downgrade B. Riley Securities Buy → Neutral
2023-01-09 Reiterato B. Riley Securities Buy
2022-12-30 Reiterato H.C. Wainwright Buy
2022-12-02 Iniziato Jefferies Hold
2022-09-22 Downgrade JP Morgan Neutral → Underweight
2022-05-20 Iniziato BofA Securities Underperform
2022-02-23 Reiterato B. Riley Securities Buy
2022-02-22 Ripresa Jefferies Buy
2022-01-21 Iniziato Cowen Outperform
2021-05-12 Downgrade JP Morgan Overweight → Neutral
2020-12-14 Iniziato Jefferies Buy
2020-08-06 Reiterato H.C. Wainwright Buy
2020-08-05 Aggiornamento JP Morgan Neutral → Overweight
2020-08-05 Downgrade Ladenburg Thalmann Neutral → Sell
2020-07-16 Reiterato H.C. Wainwright Buy
2020-07-08 Downgrade Ladenburg Thalmann Buy → Neutral
2020-06-29 Reiterato B. Riley FBR Buy
2020-06-29 Reiterato H.C. Wainwright Buy
2020-06-05 Aggiornamento JP Morgan Underweight → Neutral
2020-05-28 Reiterato B. Riley FBR Buy
2020-05-12 Reiterato H.C. Wainwright Buy
2020-04-30 Reiterato H.C. Wainwright Buy
2019-11-27 Ripresa B. Riley FBR Buy
2019-08-14 Reiterato H.C. Wainwright Buy
2019-02-28 Downgrade Piper Jaffray Overweight → Underweight
2018-12-18 Iniziato Ladenburg Thalmann Buy
2018-12-11 Iniziato Oppenheimer Outperform
2018-11-26 Aggiornamento Piper Jaffray Neutral → Overweight
2018-09-21 Aggiornamento JP Morgan Underweight → Overweight
2018-03-29 Aggiornamento Seaport Global Securities Neutral → Buy
Mostra tutto

Novavax Inc Borsa (NVAX) Ultime notizie

pulisher
05:56 AM

Novavax stock today: NVAX closes up 6% as Singapore rolls out JN.1 Novavax COVID shot - ts2.tech

05:56 AM
pulisher
01:55 AM

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

01:55 AM
pulisher
Jan 02, 2026

Novavax (NVAX) Stock Trades Up, Here Is Why - Finviz

Jan 02, 2026
pulisher
Jan 02, 2026

Risk Hedge: Is Novavax Inc NVV1 stock undervalued after correctionEarnings Beat & Real-Time Buy Signal Alerts - moha.gov.vn

Jan 02, 2026
pulisher
Jan 02, 2026

Aug Analyst Calls: Should I hold or sell Novavax Inc stock in 2025July 2025 Weekly Recap & Stepwise Trade Execution Plans - moha.gov.vn

Jan 02, 2026
pulisher
Jan 01, 2026

Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales - Yahoo Finance

Jan 01, 2026
pulisher
Dec 30, 2025

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Dec 30, 2025
pulisher
Dec 30, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Novavax (NVAX), Xenon (XENE) and Biohaven Ltd. (BHVN) - The Globe and Mail

Dec 30, 2025
pulisher
Dec 30, 2025

Investor Mood: How strong is Novavax Inc stock balance sheetJuly 2025 Chart Watch & Accurate Buy Signal Notifications - moha.gov.vn

Dec 30, 2025
pulisher
Dec 30, 2025

NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback? - ts2.tech

Dec 30, 2025
pulisher
Dec 25, 2025

Trading Systems Reacting to (NVAX) Volatility - Stock Traders Daily

Dec 25, 2025
pulisher
Dec 24, 2025

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

Dec 24, 2025
pulisher
Dec 23, 2025

Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 23, 2025
pulisher
Dec 23, 2025

What valuation multiples suggest for Novavax Inc stockWeekly Gains Report & Weekly Watchlist of Top Performers - moha.gov.vn

Dec 23, 2025
pulisher
Dec 20, 2025

Evaluating Novavax’s Current Valuation After Steep Five Year Share Price Collapse - Yahoo Finance

Dec 20, 2025
pulisher
Dec 20, 2025

Why Novavax Inc. stock is favored by pension fundsJuly 2025 Final Week & Consistent Profit Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will Novavax Inc. stock gain from strong economyWeekly Profit Recap & Fast Moving Trade Plans - Bölüm Sonu Canavarı

Dec 20, 2025
pulisher
Dec 20, 2025

Will Novavax Inc. stock outperform international peersQuarterly Portfolio Review & Weekly Top Gainers Trade List - ulpravda.ru

Dec 20, 2025
pulisher
Dec 19, 2025

Interesting NVAX Call Options For February 2026 - Nasdaq

Dec 19, 2025
pulisher
Dec 19, 2025

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance

Dec 19, 2025
pulisher
Dec 19, 2025

Should I hold or sell Novavax Inc. stock in 2025Trade Performance Summary & Low Risk High Win Rate Picks - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Why Novavax Inc. stock is trending among retail traders2025 Volume Leaders & Stepwise Entry and Exit Trade Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Market Trends: Why Novavax Inc. stock remains a top recommendationTrade Volume Report & Verified Stock Trade Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

What hedge fund activity signals for Novavax Inc. stockWatch List & Free Accurate Trade Setup Notifications - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛

Dec 19, 2025
pulisher
Dec 19, 2025

How strong is Novavax Inc. stock balance sheet2025 Technical Overview & Community Verified Watchlist Alerts - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 16, 2025

Pfizer leads COVID-19 vaccine peers lower after revamped guidance - Seeking Alpha

Dec 16, 2025
pulisher
Dec 15, 2025

VP Casey Acquires 29,186 Of Novavax Inc [NVAX] - TradingView — Track All Markets

Dec 15, 2025
pulisher
Dec 15, 2025

Novavax Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛

Dec 15, 2025
pulisher
Dec 14, 2025

Avoiding Lag: Real-Time Signals in (NVAX) Movement - news.stocktradersdaily.com

Dec 14, 2025
pulisher
Dec 13, 2025

Revenue Check: Why Novavax Inc stock is trending among retail traders2025 Top Decliners & Stepwise Swing Trade Plans - moha.gov.vn

Dec 13, 2025
pulisher
Dec 12, 2025

Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch

Dec 12, 2025
pulisher
Dec 12, 2025

FDA intends to put most serious warning on COVID vaccines, CNN reports - Reuters

Dec 12, 2025
pulisher
Dec 11, 2025

CDC study finds COVID shot significantly reduced ER visits for children - Seeking Alpha

Dec 11, 2025
pulisher
Dec 11, 2025

Why I wouldn't touch Novavax with a 10-foot pole - MSN

Dec 11, 2025
pulisher
Dec 11, 2025

Why I Wouldn't Touch Novavax With a 10-Foot Pole - Yahoo Finance

Dec 11, 2025
pulisher
Dec 10, 2025

Novavax Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Dec 10, 2025
pulisher
Dec 09, 2025

Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛

Dec 09, 2025
pulisher
Dec 08, 2025

Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch

Dec 08, 2025
pulisher
Dec 08, 2025

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - Yahoo Finance

Dec 08, 2025
pulisher
Dec 05, 2025

Lobbying Update: $30,000 of NOVAVAX lobbying was just disclosed - Quiver Quantitative

Dec 05, 2025
pulisher
Dec 05, 2025

Novavax, Inc. (NVAX): A Bull Case Theory - Finviz

Dec 05, 2025
pulisher
Dec 05, 2025

Novavax, Inc. (NVAX): A bull case theory - MSN

Dec 05, 2025
pulisher
Dec 05, 2025

Will Novavax Inc. (NVV1) stock deliver stable dividendsMarket Movement Recap & Verified Technical Signals - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How Novavax Inc. (NVV1) stock benefits from digital adoptionJuly 2025 Action & Weekly Breakout Watchlists - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How Novavax Inc. (NVV1) stock gains from tech spendingRisk Management & Weekly Stock Performance Updates - Newser

Dec 04, 2025

Novavax Inc Azioni (NVAX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Novavax Inc Azioni (NVAX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Draghia-Akli Ruxandra
Section 16
Nov 11 '25
Option Exercise
0.00
14,257
0
14,257
MCGLYNN MARGARET G
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
25,588
Alton Gregg H
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
28,805
King Rachel K.
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
25,190
Rodgers Richard J
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
24,690
MOTT DAVID M
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
60,890
DOUGLAS RICHARD
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
54,340
$38.86
price up icon 0.57%
$31.82
price up icon 3.31%
$101.42
price up icon 2.68%
$96.69
price up icon 1.57%
biotechnology ONC
$311.02
price up icon 2.37%
$177.12
price up icon 1.77%
Capitalizzazione:     |  Volume (24 ore):